{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:00:28Z","timestamp":1762160428972,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.jsbmb.2005.06.010","type":"journal-article","created":{"date-parts":[[2005,7,26]],"date-time":"2005-07-26T15:08:29Z","timestamp":1122390509000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["The rationale for deltanoids in therapy for myeloid leukemia: Role of KSR\u2013MAPK\u2013C\/EBP pathway"],"prefix":"10.1016","volume":"97","author":[{"given":"George P.","family":"Studzinski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuening","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Kutner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan S.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jsbmb.2005.06.010_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.yexcr.2004.04.029","article-title":"Enhancement by other compounds of the anti-cancer activity of Vitamin D3 and its analogs","volume":"298","author":"Danilenko","year":"2004","journal-title":"Exp. Cell Res."},{"issue":"9","key":"10.1016\/j.jsbmb.2005.06.010_bib2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0039-128X(02)00038-7","article-title":"Synthesis and antiproliferative activity of side-chain unsaturated and homologated analogs of 1,25-dihydroxyvitamin D2","volume":"67","author":"Chodynski","year":"2002","journal-title":"Steroids"},{"issue":"11\u20135","key":"10.1016\/j.jsbmb.2005.06.010_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jsbmb.2004.03.018","article-title":"Neuroprotective effects of (24R)-1,24-dihydroxycholecalciferol in human neuroblastoma SH-SY5Y cell line","volume":"89\u201390","author":"Tetich","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"10","key":"10.1016\/j.jsbmb.2005.06.010_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.steroids.2004.05.015","article-title":"Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191)","volume":"69","author":"Wietrzyk","year":"2004","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.jsbmb.2005.06.010_bib5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood.V54.3.713.713","article-title":"Characterization of the continuous, differentiating myeloid cell line (HL60) from a patient with acute promyelocytic leukemia","volume":"54","author":"Gallagher","year":"1979","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.jsbmb.2005.06.010_bib6","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/jnci\/89.16.1199","article-title":"Synergistic induction of HL60 cell differentiation by ketoconazole and 1-desoxy analogs of vitamin D3","volume":"20","author":"Wang","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.jsbmb.2005.06.010_bib7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jcb.10423","article-title":"New insights into the mechanisms of Vitamin D action","volume":"88","author":"Christakos","year":"2003","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jsbmb.2005.06.010_bib8","series-title":"Vitamin D","first-page":"179","article-title":"Regulation of Vitamin D receptor abundance","author":"Krishnan","year":"1997"},{"issue":"1\u20135","key":"10.1016\/j.jsbmb.2005.06.010_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jsbmb.2004.03.078","article-title":"Vitamin D receptor B1 and exon 1d: functional and evolutionary analysis","volume":"89\u201390","author":"Gardiner","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"3\u20138","key":"10.1016\/j.jsbmb.2005.06.010_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0960-0760(92)90349-N","article-title":"1,25(OH)2-Vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways","volume":"41","author":"Norman","year":"1992","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.jsbmb.2005.06.010_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000046902","article-title":"A run for a membrane Vitamin D receptor","volume":"10","author":"Marcinkowska","year":"2001","journal-title":"Biol. Signals Recept."},{"issue":"2","key":"10.1016\/j.jsbmb.2005.06.010_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/excr.2000.4939","article-title":"Inhibition of p38 MAP kinase activity up-regulates multiple MAP kinase pathways and potentiates 1,25-dihydroxyvitamin D3-induced differentiation of human leukemia HL60 cells","volume":"258","author":"Wang","year":"2000","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.jsbmb.2005.06.010_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/1097-4644(20010315)80:4<471::AID-JCB1001>3.0.CO;2-J","article-title":"Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells","volume":"80","author":"Wang","year":"2001","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.jsbmb.2005.06.010_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jcb.1141","article-title":"Inhibition of p38MAP kinase potentiates the JNK\/SAPK pathway and AP-1 activity in monocytic but not in macrophage or granulocytic differentiation of HL60 cells","volume":"82","author":"Wang","year":"2001","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.jsbmb.2005.06.010_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/excr.2001.5292","article-title":"Phosphorylation of raf-1 by kinase suppressor of ras is inhibited by \u201cMEK-specific\u201d inhibitors PD 098059 and U0126 in differentiating HL60 cells","volume":"268","author":"Wang","year":"2001","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.jsbmb.2005.06.010_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.18388\/abp.2002_3798","article-title":"Side-chain modified Vitamin D analogs require activation of both PI 3-K and Erk 1,2 signal transduction pathways to induce differentiation of human promyelocytic leukemia cells","volume":"49","author":"Marcinkowska","year":"2002","journal-title":"Acta Biochim. Pol."},{"issue":"6","key":"10.1016\/j.jsbmb.2005.06.010_bib17","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/jcb.10595","article-title":"Jun N-terminal kinase pathway enhances signaling of monocytic differentiation of human leukemia cells induced by 1,25-dihydroxyvitamin D3","volume":"89","author":"Wang","year":"2003","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.jsbmb.2005.06.010_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jcp.10443","article-title":"Kinase suppressor of RAS (KSR) amplifies the differentiation signal provided by low concentrations 1,25-dihydroxyvitamin D3","volume":"198","author":"Wang","year":"2004","journal-title":"J. Cell. Physiol."},{"issue":"15","key":"10.1016\/j.jsbmb.2005.06.010_bib19","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1158\/0008-5472.CAN-04-0806","article-title":"Up-regulation of Egr1 by 1,25-dihydroxyvitamin D3 contributes to increased expression of p35 activator of cyclin-dependent kinase 5 and consequent onset of the terminal phase of HL60 cell differentiation","volume":"64","author":"Chen","year":"2004","journal-title":"Cancer Res."},{"issue":"26","key":"10.1016\/j.jsbmb.2005.06.010_bib20","doi-asserted-by":"crossref","first-page":"15823","DOI":"10.1016\/S0021-9258(18)55472-7","article-title":"Role of ceramide as a lipid mediator of 1 alpha, 25-dihydroxyvitamin D3-induced HL-60 cell differentiation","volume":"265","author":"Okazaki","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.jsbmb.2005.06.010_bib21","doi-asserted-by":"crossref","first-page":"12792","DOI":"10.1073\/pnas.94.24.12792","article-title":"KSR stimulates Raf-1 activity in a kinase-independent manner","volume":"94","author":"Michaud","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.jsbmb.2005.06.010_bib22","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1242\/jcs.114.9.1609","article-title":"KSR: a MAPK scaffold of the Ras pathway","volume":"114","author":"Morrison","year":"2001","journal-title":"J. Cell Sci."},{"issue":"23","key":"10.1016\/j.jsbmb.2005.06.010_bib23","doi-asserted-by":"crossref","first-page":"17276","DOI":"10.1074\/jbc.C900989199","article-title":"Epidermal growth factor treatment enhances the kinase activity of kinase suppressor of Ras","volume":"275","author":"Xing","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.jsbmb.2005.06.010_bib24","first-page":"963","article-title":"Kinase suppressor of Ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase\/mitogen-activated protein kinase in intestinal epithelial cells","volume":"61","author":"Yan","year":"2001","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.jsbmb.2005.06.010_bib25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4161\/cc.1.6.269","article-title":"Derivatives of Vitamins D2 and D3 activate three MAPK pathways and upregulate pRb expression in differentiating HL60 cells","volume":"1","author":"Ji","year":"2002","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.jsbmb.2005.06.010_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1021\/bi00453a026","article-title":"24-homologated 1,25-dihydroxyvitamin D3 compounds: separation of calcium and cell differentiation activities","volume":"29","author":"Perlman","year":"1990","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.jsbmb.2005.06.010_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4161\/cc.1.2.108","article-title":"The restriction point of the cell cycle","volume":"1","author":"Blagosklonny","year":"2002","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.jsbmb.2005.06.010_bib28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1073\/pnas.94.2.569","article-title":"Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice","volume":"94","author":"Zhang","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"52","key":"10.1016\/j.jsbmb.2005.06.010_bib29","doi-asserted-by":"crossref","first-page":"52651","DOI":"10.1074\/jbc.M307077200","article-title":"Restoration of C\/EBP alpha expression in a BCR-ABL+ cell line induces terminal granulocytic differentiation","volume":"278","author":"Tavor","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.jsbmb.2005.06.010_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/85820","article-title":"Dominant-negative mutations of CEBPA, encoding CCAAT\/enhancer binding protein-alpha (C\/EBPalpha), in acute myeloid leukemia","volume":"27","author":"Pabst","year":"2001","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.jsbmb.2005.06.010_bib31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/MCB.25.1.472-487.2005","article-title":"Functional cooperation between CCAAT\/enhancer-binding proteins and the Vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase","volume":"25","author":"Dhawan","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2005.06.010_bib32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1158\/0008-5472.CAN-03-3029","article-title":"Retinoblastoma protein and CCAAT\/enhancer-binding protein beta are required for 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL60 cells","volume":"64","author":"Ji","year":"2004","journal-title":"Cancer Res."},{"issue":"33","key":"10.1016\/j.jsbmb.2005.06.010_bib33","doi-asserted-by":"crossref","first-page":"23242","DOI":"10.1074\/jbc.274.33.23242","article-title":"CCAAT\/enhancer-binding protein activates the CD14 promoter and mediates transforming growth factor beta signaling in monocyte development","volume":"274","author":"Pan","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"46","key":"10.1016\/j.jsbmb.2005.06.010_bib34","doi-asserted-by":"crossref","first-page":"27489","DOI":"10.1074\/jbc.270.46.27489","article-title":"PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo","volume":"270","author":"Alessi","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.jsbmb.2005.06.010_bib35","doi-asserted-by":"crossref","first-page":"9402","DOI":"10.1074\/jbc.M211262200","article-title":"Anthrax lethal factor proteolysis and inactivation of MAPK kinase","volume":"278","author":"Chopra","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.jsbmb.2005.06.010_bib36","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/jnci\/93.16.1224","article-title":"Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents","volume":"93","author":"Danilenko","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jsbmb.2005.06.010_bib37","unstructured":"M. Danilenko, Q. Wang, X. Wang, J. Levy, Y. Sharoni, G.P. Studzinski, Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1alpha,25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium, Cancer Res. 63 (6) (2003) 1325\u20131332."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076005002359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076005002359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:51:37Z","timestamp":1760734297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076005002359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":37,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0960076005002359"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2005.06.010","relation":{},"ISSN":["0960-0760"],"issn-type":[{"type":"print","value":"0960-0760"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The rationale for deltanoids in therapy for myeloid leukemia: Role of KSR\u2013MAPK\u2013C\/EBP pathway","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2005.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}